Vulnerability · CVE-2020-37014
Tryton 5.4 contains a persistent cross-site scripting vulnerability in the user profile name input that allows remote attackers to inject malicious scripts.
Published Jan 30, 2026 · catalog updated May 14, 2026 · Tryton
Last checked Nov 5, 2026. A connected source was read within the last 7 days.
Check if you run it
No confirmed exploitation is on record for CVE-2020-37014. EPSS is 0.37%. Act only if a listed version of Tryton is installed.
Gaps on this record
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.37%
- Remediation
- Vendor / distro source
- Affected products
- vendor tryton Tryton 0 ≤5.4
Tryton 5.4 contains a persistent cross-site scripting vulnerability in the user profile name input that allows remote attackers to inject malicious scripts. Attackers can exploit the vulnerability by inserting script payloads in the name field, which execute in the frontend and backend user interfaces.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor tryton Tryton 0 ≤5.40 ≤5.4
How to fix CVE-2020-37014
No stored fix
No vendor fix text is stored. Use the linked advisory before you change production.
Version check
Seen in 0 ≤5.4
Advisory
Open the cve_org record and follow its fix.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2020-37014. EPSS is 0.37%. Act only if a listed version of Tryton is installed.
Which versions are affected?
Compare what you have installed with tryton Tryton 0 ≤5.4 0 ≤5.4. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.37%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Jan 30, 2026 · EUVD
Detected
Tryton 5.4 contains a persistent cross-site scripting vulnerability in the user profile name input that allows remote attackers to inject malicious scripts. Attackers can exploit the vulnerability by inserting script payloads in the name field, which execute in the frontend and backend user interfaces.
May 14, 2026 · EUVD
Updated
Tryton 5.4 contains a persistent cross-site scripting vulnerability in the user profile name input that allows remote attackers to inject malicious scripts. Attackers can exploit the vulnerability by inserting script payloads in the name field, which execute in the frontend and backend user interfaces.
Sources
- CVE.orgVulnerability recordCVE-2020-37014
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2020-37014
30-day exploitation probability 0.37%
first.org - EUVDVulnerability recordEUVD-2020-30960
Tryton 5.4 contains a persistent cross-site scripting vulnerability in the user profile name input that allows remote attackers to inject malicious scripts. Attackers can exploit the vulnerability by inserting script payloads in the name field, which execute in the frontend and b
euvd.enisa.europa.eu
References
Freshness
Last verified in this catalog Nov 5, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.
- FIRST EPSSNov 5, 2026
- CVE.orgNov 4, 2026
- EUVDNov 2, 2026